Barinthus Capital Lease Obligations vs Net Tangible Assets Analysis
| BRNS Stock | 0.95 0.02 2.06% |
Barinthus Biotherapeutics financial indicator trend analysis is way more than just evaluating Barinthus Biotherapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Barinthus Biotherapeutics is a good investment. Please check the relationship between Barinthus Biotherapeutics Capital Lease Obligations and its Net Tangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Barinthus Biotherapeutics plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Capital Lease Obligations vs Net Tangible Assets
Capital Lease Obligations vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Barinthus Biotherapeutics Capital Lease Obligations account and Net Tangible Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Barinthus Biotherapeutics' Capital Lease Obligations and Net Tangible Assets is 0.94. Overlapping area represents the amount of variation of Capital Lease Obligations that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Barinthus Biotherapeutics plc, assuming nothing else is changed. The correlation between historical values of Barinthus Biotherapeutics' Capital Lease Obligations and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Lease Obligations of Barinthus Biotherapeutics plc are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Capital Lease Obligations i.e., Barinthus Biotherapeutics' Capital Lease Obligations and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.94 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Capital Lease Obligations
Barinthus Biotherapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Barinthus Biotherapeutics asset purchases. For example, Barinthus Biotherapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Barinthus Biotherapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Barinthus Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Barinthus Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Barinthus Biotherapeutics plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Tax Provision is likely to gain to about (4.1 M) in 2024. Selling General Administrative is likely to drop to about 22.5 M in 2024
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.7M | 19K | 28K | 26.6K | Depreciation And Amortization | 601.9K | 5.5M | 5.5M | 5.7M |
Barinthus Biotherapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Barinthus Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Barinthus Stock Analysis
When running Barinthus Biotherapeutics' price analysis, check to measure Barinthus Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barinthus Biotherapeutics is operating at the current time. Most of Barinthus Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Barinthus Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barinthus Biotherapeutics' price. Additionally, you may evaluate how the addition of Barinthus Biotherapeutics to your portfolios can decrease your overall portfolio volatility.